Financial Performance - Total operating revenue for Q3 2024 reached CNY 7,358,929,828.38, an increase of 54.08% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2024 was CNY 2,402,057,661.53, representing an 88.90% increase year-on-year[4] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 2,118,508,547.96, up 62.68% from the previous year[4] - Basic and diluted earnings per share for Q3 2024 were both CNY 0.29, reflecting a 107.14% increase compared to the same period last year[4] - Total revenue for the period reached CNY 19,137,048,463.57, an increase from CNY 18,013,657,311.89 in the previous period, reflecting a growth of approximately 6.22%[17] - The total profit for the current period is approximately ¥8.18 billion, an increase from ¥7.39 billion in the previous period, representing a growth of about 10.76%[18] - Net profit for the current period is approximately ¥7.50 billion, up from ¥6.54 billion, reflecting a year-over-year increase of about 14.69%[18] - The total comprehensive income attributable to the parent company's owners is approximately ¥7.96 billion, an increase from ¥6.35 billion, representing a growth of about 25.51%[18] Cash Flow - The net cash flow from operating activities for the year-to-date period reached CNY 31,163,341,650.54, a significant increase of 150.77%[4] - Net cash flow from operating activities rose by 150.77% to ¥31,163,341,650.54, up from ¥12,427,006,624.21 in the previous year[7] - The net cash flow from operating activities is approximately ¥31.16 billion, significantly higher than ¥12.43 billion in the previous period, indicating a growth of about 150.00%[19] - Cash inflow from investment activities is approximately ¥12.04 billion, compared to ¥4.29 billion in the previous period, marking an increase of about 180.00%[19] - The net cash flow from financing activities shows a negative value of approximately -¥10.73 billion, worsening from -¥8.78 billion in the previous period[20] - The company reported a significant increase in cash received from interest, fees, and commissions, totaling approximately ¥17.56 billion, compared to ¥19.32 billion in the previous period[19] Assets and Liabilities - Total assets as of September 30, 2024, amounted to CNY 770,653,448,432.52, a 12.97% increase from the end of the previous year[4] - Total liabilities rose to CNY 622,558,737,908.07, compared to CNY 541,505,969,211.81 at the end of 2023, indicating an increase of around 14.98%[15] - The company's equity attributable to shareholders increased to CNY 142,788,719,467.83 from CNY 135,717,647,870.07, reflecting a growth of approximately 5.93%[16] - The total equity increased to CNY 148,094,710,524.45 from CNY 140,675,710,016.60, reflecting a growth of approximately 5.88%[16] Investment and Income - Investment income increased by 62.26% to ¥5,551,476,128.36 from ¥3,421,421,290.10 year-on-year[7] - Investment income surged to CNY 5,551,476,128.36, up from CNY 3,421,421,290.10, representing an increase of about 62.19%[17] - Other business income surged by 247.92% to ¥641,810,443.32, driven by increased sales of bulk commodities[7] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 217,432, with the top ten shareholders holding significant stakes[9] - The largest shareholder, Hong Kong Central Clearing Limited, holds 22.31% of the shares, totaling 1,700,170,760 shares[9] - Jilin Aodong Pharmaceutical Group holds 1,252,768,767 A-shares, accounting for approximately 20.05% of the total share capital[10] - Liaoning Chengda holds 1,250,154,088 A-shares, representing about 17.94% of the total share capital[10] - As of September 30, 2024, Jilin Aodong and its concerted actors hold a total of 3.61% of the company's H-shares[10] - The top 10 unrestricted shareholders hold a total of 1,700,170,760 H-shares, representing a significant portion of the company's equity[10] Financial Ratios - The weighted average return on net assets increased by 0.90 percentage points to 1.85% for Q3 2024[4] - Risk coverage ratio increased to 235.09%, up by 1.73 percentage points from 233.36%[8] - The liquidity coverage ratio decreased significantly by 89.21 percentage points to 133.22% from 222.43%[8] Capital and Contributions - The company increased its capital contribution to GF Holdings (Hong Kong) by HKD 1.1 billion, raising its paid-in capital to HKD 8.2 billion[12] - GF Financial Holdings BVI Ltd. issued USD 300 million in floating rate bonds with a 3-year term, guaranteed by the company[13] - The company has 26 branches and 331 securities business departments, totaling 357 institutions across 31 provinces and municipalities[12] Other Financial Metrics - Core net capital decreased by 1.47% to ¥64,554,987,081.19 from ¥65,515,503,102.87 at the end of the previous year[8] - Total net capital declined by 1.62% to ¥91,654,987,081.19 compared to ¥93,165,503,102.87 at the end of last year[8] - The company maintained a stable capital reserve of CNY 31,275,141,062.93, slightly decreasing from CNY 31,296,847,770.85[16] - The company received approximately ¥2.00 billion from issuing perpetual bonds during the current period, down from ¥11.50 billion in the previous period[20]
广发证券(01776) - 2024 Q3 - 季度业绩